Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cibus Inc CBUS

Healthcare Biotechnology
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant... see more

Recent & Breaking News (NDAQ:CBUS)

Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Eastern Time

PR Newswire October 19, 2021

Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board

PR Newswire October 12, 2021

Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers

PR Newswire October 5, 2021

Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative

PR Newswire September 28, 2021

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference

PR Newswire September 7, 2021

Calyxt Reports Second Quarter 2021 Financial Results

PR Newswire August 5, 2021

Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021

PR Newswire August 4, 2021

Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire July 27, 2021

Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time

PR Newswire July 19, 2021

Calyxt Appoints Michael A. Carr as Chief Executive Officer

PR Newswire July 15, 2021

Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation

Accesswire July 8, 2021

Calyxt Reports First Quarter 2021 Financial Results

Accesswire May 6, 2021

Calyxt Announces Next Generation Premium Soybean Product Line Performance Best-In-Class for High Oleic, Ultra-Low Linolenic Profile

Accesswire May 4, 2021

Calyxt Successfully Transforms Hemp Genome

Accesswire April 29, 2021

Calyxt to Present at Upcoming Investor and Industry Conferences

Accesswire April 20, 2021

Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results

Accesswire March 4, 2021

Calyxt to Present at Upcoming March Investor Conferences

Accesswire March 3, 2021

Calyxt Completes New Scientific Advisory Board with Key Appointments

Accesswire March 2, 2021

Calyxt Announces High Oleic Soybean Seed Sales Agreement with Perdue AgriBusiness

Accesswire February 23, 2021

Calyxt Announces Dr. Yves Ribeill Appointed As Executive Chair Replacing CEO Jim Blome

Accesswire February 19, 2021